Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Chouaid

Showing results (111-120 of 209) with videos related to

Pageof 21
Sort By:
Cancers|November 9, 2024
Optimizing Treatment Strategies for <i>Egfr</i>-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and InsightsQuentin Dominique Thomas, Nicolas Girard, Lise Bosquet, et al.
Age and Ageing|January 3, 2026
Reliability of the cumulative illness rating scale for geriatrics for assessing multimorbidity in older patients with cancer: results from the ELCAPA cohortMarc A Benderra, Philippe Caillet, Amélie Aregui, et al.
Frontiers in Immunology|May 4, 2026
Case Report: Complete metabolic responses to trastuzumab-deruxtecan in HER2-altered solid tumors: two illustrative casesColine Le Meur, Pierre-Yves Le Roux, Pierre Alemany, et al.
Frontiers in Pharmacology|March 7, 2024
Lung cancer, comorbidities, and medication: the infernal trioHélène Pluchart, Sébastien Chanoine, Denis Moro-Sibilot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2011
Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601)Chantal Decroisette, Isabelle Monnet, Henri Berard, et al.
Cancers|January 11, 2022
Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort ExperienceTina Lamy, Bastien Cabarrou, David Planchard, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survivalHelene Doubre, Isabelle Monnet, Reza Azarian, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 16, 2019
Continuity of care in general practice at cancer diagnosis (COOC-GP study): a national cohort study of 2853 patientsAline Hurtaud, Michèle Aubin, Emilie Ferrat, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Translational Oncology|March 26, 2019
Isolated 5' Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the LiteratureAlice Guyard, Cécile Charpy, Nathalie Théou-Anton, et al.
Pageof 21

Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
Cancers|November 9, 2024
Optimizing Treatment Strategies for <i>Egfr</i>-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and InsightsQuentin Dominique Thomas, Nicolas Girard, Lise Bosquet, et al.
Age and Ageing|January 3, 2026
Reliability of the cumulative illness rating scale for geriatrics for assessing multimorbidity in older patients with cancer: results from the ELCAPA cohortMarc A Benderra, Philippe Caillet, Amélie Aregui, et al.
Frontiers in Immunology|May 4, 2026
Case Report: Complete metabolic responses to trastuzumab-deruxtecan in HER2-altered solid tumors: two illustrative casesColine Le Meur, Pierre-Yves Le Roux, Pierre Alemany, et al.
Frontiers in Pharmacology|March 7, 2024
Lung cancer, comorbidities, and medication: the infernal trioHélène Pluchart, Sébastien Chanoine, Denis Moro-Sibilot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2011
Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601)Chantal Decroisette, Isabelle Monnet, Henri Berard, et al.
Cancers|January 11, 2022
Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort ExperienceTina Lamy, Bastien Cabarrou, David Planchard, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survivalHelene Doubre, Isabelle Monnet, Reza Azarian, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 16, 2019
Continuity of care in general practice at cancer diagnosis (COOC-GP study): a national cohort study of 2853 patientsAline Hurtaud, Michèle Aubin, Emilie Ferrat, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Translational Oncology|March 26, 2019
Isolated 5' Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the LiteratureAlice Guyard, Cécile Charpy, Nathalie Théou-Anton, et al.
Pageof 21